These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34554906)

  • 1. Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.
    Gbefon CY; Sobral CPS; Caldas A; Rocha VCC; Azulay RSS; Nascimento GC; Damianse SSP; Gaspar SAS; Faria MS; Magalhães M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2231-2237. PubMed ID: 34554906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis.
    Wang Q; Zhao Z; Shen H; Bing Q; Li N; Hu J
    Channels (Austin); 2021 Dec; 15(1):20-30. PubMed ID: 33345742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.
    Brugnoni R; Canioni E; Filosto M; Pini A; Tonin P; Rossi T; Canavese C; Eoli M; Siciliano G; Lauria G; Mantegazza R; Maggi L
    Neurogenetics; 2022 Jan; 23(1):19-25. PubMed ID: 34608571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis.
    Wang XY; Ren BW; Yong ZH; Xu HY; Fu QX; Yao HB
    Mol Med Rep; 2015 Oct; 12(4):6267-74. PubMed ID: 26252573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does thyrotoxic periodic paralysis have a genetic predisposition? A case report.
    Rasheed E; Seheult J; Gibney J; Boran G
    Ann Clin Biochem; 2018 Nov; 55(6):713-716. PubMed ID: 29886759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis.
    Schalin-Jantti C; Laine T; Valli-Jaakola K; Lonnqvist T; Kontula K; Valimaki MJ
    Horm Res; 2005; 63(3):139-44. PubMed ID: 15795511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms.
    Paninka RM; Mazzotti DR; Kizys MM; Vidi AC; Rodrigues H; Silva SP; Kunii IS; Furuzawa GK; Arcisio-Miranda M; Dias-da-Silva MR
    Mol Genet Genomics; 2016 Aug; 291(4):1535-44. PubMed ID: 27008341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.
    Cheng CJ; Lin SH; Lo YF; Yang SS; Hsu YJ; Cannon SC; Huang CL
    J Biol Chem; 2011 Aug; 286(31):27425-35. PubMed ID: 21665951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to
    Çetin T; Turan İ
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):362-366. PubMed ID: 33389921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Ryan DP; da Silva MR; Soong TW; Fontaine B; Donaldson MR; Kung AW; Jongjaroenprasert W; Liang MC; Khoo DH; Cheah JS; Ho SC; Bernstein HS; Maciel RM; Brown RH; Ptácek LJ
    Cell; 2010 Jan; 140(1):88-98. PubMed ID: 20074522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.
    Li X; Yao S; Xiang Y; Zhang X; Wu X; Luo L; Huang H; Zhu M; Wan H; Hong D
    BMC Neurol; 2015 Mar; 15():38. PubMed ID: 25885757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of 37 cases with primary periodic paralysis in Chinese patients.
    Zhao X; Ning H; Liu L; Zhu C; Zhang Y; Sun G; Ren H; Kong X
    Orphanet J Rare Dis; 2024 Apr; 19(1):160. PubMed ID: 38609989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating phenotype and genotype in the periodic paralyses.
    Miller TM; Dias da Silva MR; Miller HA; Kwiecinski H; Mendell JR; Tawil R; McManis P; Griggs RC; Angelini C; Servidei S; Petajan J; Dalakas MC; Ranum LP; Fu YH; Ptácek LJ
    Neurology; 2004 Nov; 63(9):1647-55. PubMed ID: 15534250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of genetic mutations in a Chinese pedigree affected with hypokalemic periodic paralysis].
    Guo M; Zhang G; Ma S; Xu T; Peng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):74-77. PubMed ID: 29419865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype and phenotype analysis of patients with sporadic periodic paralysis.
    Sung CC; Cheng CJ; Lo YF; Lin MS; Yang SS; Hsu YC; Lin SH
    Am J Med Sci; 2012 Apr; 343(4):281-5. PubMed ID: 21841462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Kir2.6 mutation associated with hypokalemic periodic paralysis.
    Zheng J; Liang Z; Hou Y; Liu F; Hu Y; Lin P; Yan C
    Clin Neurophysiol; 2016 Jun; 127(6):2503-8. PubMed ID: 27178871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients].
    Silva MR; Chiamolera MI; Kasamatsu TS; Cerutti JM; Maciel RM
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):196-215. PubMed ID: 15611833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations.
    Shibano M; Kubota T; Kokubun N; Miyaji Y; Kuriki H; Ito Y; Hamanoue H; Takahashi MP
    Muscle Nerve; 2022 Dec; 66(6):757-761. PubMed ID: 36116128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.